Skip to main content

Table 1 Correlation between KHSRP levels in NSCLC patients and their clinicopathologic characteristics

From: RNA-binding protein KHSRP promotes tumor growth and metastasis in non-small cell lung cancer

Clinical pathology KHSRP Levels N P Value
Low Middle High
Gender
 Male 5 (12.82%) 15 (38.46%) 19 (48.72%) 39  
 Female 10 (27.78%) 10 (27.78%) 16 (44.44%) 36 0.2338
Age
 < 60 6 (20.00%) 6 (20.00%) 18 (60.00%) 30  
 ≥ 60 9 (20.00%) 19 (42.22%) 17 (37.78%) 45 0.2730
Tumor size (cm)
 ≤ 3 7 (17.07%) 13 (31.71%) 21 (51.22%) 41  
 > 3 8 (23.53%) 12 (35.29%) 14 (41.18%) 34 0.4663
Histological grade
 I- II 2 (15.38%) 5 (38.46%) 6 (46.15%) 13  
 II 10 (22.73%) 15 (34.09%) 19 (43.18%) 44 0.3785
 II - IV 3 (16.67%) 5 (27.78%) 10 (55.56%) 18  
Clinical Stage
 T1 + T2 13 (5.45%) 20 (36.36%) 22 (40.00%) 55  
 T3 + T4 2 (10.00%) 5 (25.00%) 13 (65.00%) 20 0.0121*
Lymph node status
 Metastasis 2 (9.52%) 6 (28.57%) 13 (61.90%) 21  
 No metastasis 13 (24.07%) 19 (35.19%) 22 (40.74%) 54 0.0166*
Carcinoma
 Primary 15 (20.00%) 25 (33.33%) 35 (46.67%) 75  
 Adjacent 60 (80.00%) 12 (16.00%) 3 (4.00%) 75 0.0000*
  1. P value represents the probability from a chi-square test for tissue KHSRP levels between variable subgroups, *P < 0.05